coretrustlab

Switching from semaglutide to tirzepatide may be considered for patients who need improved blood sugar control or additional weight management support. Both medications are injectable treatments used for type 2 diabetes and weight loss, but tirzepatide works on two hormone receptors (GLP-1 and GIP), which may provide enhanced effects for some individuals.